Cas12a tracrRNA Tethering for Higher Genome Editing Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing genome editing technologies, particularly those utilizing Cas12a systems, face inefficiencies in targeting and modifying specific DNA sequences, which can be enhanced by tethering functional RNA molecules to Cas12a crRNA for improved genome editing capabilities.

Innovation Solution

The method involves hybridizing a functional RNA molecule with a Cas12a tracrRNA and a crRNA extension to tether them, forming a Cas12a ribonucleoprotein complex, and using this complex to insert or modify nucleotide sequences at specific loci in target DNA, enhanced by the presence of Cas12a tracrRNA in molar excess.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If Cas12a system is used for genome editing, then specific DNA sequences can be targeted, but editing efficiency is insufficient

Engineering Contradiction:
Improvegenome editing efficiencyVSAvoidediting capability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent combines multiple functional RNA molecules (tracrRNA and crRNA with 3' extension) into a single ribonucleoprotein complex with Cas12a nuclease. This merging of RNA components enhances the editing efficiency and reliability of the Cas12a system by creating a more stable and effective complex for targeted genome editing.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The tracrRNA serves as an intermediary molecule that facilitates the interaction between the crRNA and Cas12a nuclease. By providing a bridge that enhances complex formation and stability, the tracrRNA mediates improved editing efficiency without requiring direct modification of the target DNA sequence.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Device complexity

If tracrRNA is deleted from Cas12a system, then system simplification is achieved, but editing efficiency decreases

Engineering Contradiction:
Improvesystem complexityVSAvoidediting efficiency
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The patent changes the concentration parameter of tracrRNA by providing it in molar excess relative to Cas12a nuclease. This parameter change optimizes the formation of the ribonucleoprotein complex, ensuring that sufficient tracrRNA is available to enhance editing efficiency while maintaining system functionality.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If crRNA 3' extension is added, then functional RNA tethering is enabled, but RNA molecule complexity increases

Engineering Contradiction:
Improvefunctional RNA tethering capabilityVSAvoidRNA structure complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The crRNA is designed with a pre-added 3' extension sequence before complex formation with Cas12a and tracrRNA. This preliminary structural modification enables the crRNA to tether functional RNA molecules, providing versatility for enhanced editing capabilities while the extension sequence itself remains a defined, manageable structural element.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly enhances the genome editing efficiency by increasing the capability of Cas12a nuclease to modify target DNA sequences, allowing for precise and efficient insertion, deletion, or alteration of nucleotides in eukaryotic cells.

Implementation Method 1

hybridizing (a) a functional RNA molecule including a Cas12a tracrRNA and a functional RNA moiety; and (b) a Cas12a crRNA that includes a 3′ extension capable of hybridizing with a segment of the functional RNA molecule

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS12545910B2Compositions, systems, and methods for genome editing
Publication Date: 2026.02.10 INARI AGRICULTURE TECHNOLOGY INC
  • US12545910B2 patent drawing
  • US12545910B2 patent drawing
  • US12545910B2 patent drawing

AI summary

This disclosure provides compositions that include a polynucleotide including or encoding a Cas12a tracrRNA, and methods for their use in sequence-specific genome editing, especially of eukaryotic genomic sequences. In particular, this disclosure provides Cas12a tracrRNA-containing compositions and methods for their use in Cas12a-mediated editing of a target sequence, wherein the editing efficiency is increased in comparison to controls lacking the Cas12a tracrRNA.